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A previously unassigned group of prominent multiplets of the 360 MHz ‘H NMR spectrum of acid stable 
metabolite extracts from rat brain is shown to arise from free myo-inositol. This conclusion is derived from 
a systematic analysis of the high-resolution ‘H NMR spectra of brain acid extracts, in which appropriate 
conditions and optimal proton signals have been selected for the quantitative analysis of up to 15 metabo- 
lites. Developmental variations in the cerebral content of myo-inositol could be readily detected using this 
approach, which provides a novel alternative to study myo-inositol metabolism under physiological or path- 
ological conditions. 
Cerebral myo-inositol ‘H NMR quantitative analysis Brain development 
1. INTRODUCTION 
Adequate understanding of cerebral metabolism 
‘in situ’ demands the non-invasive study of 
metabolic transformations as they take place in 
their own intracellular environment. ‘H NMR pro- 
vides an excellent tool for detecting in situ proton 
signals from a wide variety of metabolites with the 
important advantage over 13C or 31P NMR of its 
inherently higher sensitivity. Initial studies from 
different laboratories have reported ‘in vivo’ ‘H 
NMR spectra of rat brain [1] or high-resolution 
* To whom correspondence should be addressed 
Abbrewations: AC-, acetate; BHBA, fl-hydroxybuty- 
rate; Cr, creatine; CrP, creatine phosphate; 2D COSY, 
bidimensional correlated spectroscopy; FT NMR, 
Fourier transform NMR; GABA, y-aminobutyrate; 
GPC, glycerolphosphorylcholine; Lac, lactate; myo-ino, 
myo-inositol [(1,2,3,5/4,6)cyclohexanehexol]; N-Ac- 
Asp, N-acetylaspartate; PC, phosphorylcholine; TSP, 
2,2,3,3-tetradeutero-3-trimethylsilylpropionate. Abbre- 
viations used for the amino acids are those recom- 
mended by the IUPAC-IUB Commission on Biochemi- 
cal Nomenclature 
spin-echo studies in rat or rabbit brain 
homogenates [2,3]. However, the physiological in- 
formation obtainable so far from the ‘H NMR 
spectra has been limited either by an incomplete 
assignment of resonances or by difficulties in 
signal quantitation due to partial overlapping of 
some relevant resonances. 
Here, a systematic study of the ‘H NMR spectra 
of acid extracts from rat brain has been performed 
to identify the chemical nature of previously 
unassigned signals. Cerebral free myo-inositol is 
shown to account for a prominent group of 
formerly unassigned multiplets situated in the 
high-field vicinity of the water signal. In addition, 
experimental conditions leading to optimization of 
the ‘H NMR quantitation of brain acid extracts are 
described and applied to monitor variations in the 
content of myo-inositol and other ‘H NMR detect- 
able metabolites during cerebral maturation. 
2. EXPERIMENTAL 
2.1. Animals and experimental techniques 
Male Wistar rats, 200-250 g in weight, fed ad 
libitum and allowed free access to water, were used 
in these experiments. Rat brain specimens were ob- 
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tained from anesthetized animals (25 mg/kg 
sodium pentobarbital) using the funnel freezing 
technique [4]. Six-day-old rats were processed 
similarly. 
Acid-soluble metabolites were extracted from 
single frozen pulverized brains using the 
methanol/HCl/perchloric acid procedure de- 
scribed by Lowry and Passoneau [5] as modified 
by Veech et al. [6]. The extraction protocol was 
repeated twice, the neutralized supernatants being 
combined and freeze-dried. The resulting 
lyophilized powder was dissolved in 99.8% D20 to 
approx. 0.2 g dry wt/ml, passed through a Chelex 
column and its final pH adjusted to 8 just prior to 
‘H or 13C NMR spectroscopy. 
2.2. NMR spectroscopy 
High-resolution ‘H NMR spectra at 360 MHz 
were obtained on a Bruker WM-360 spectrometer 
at a probe temperature of 20°C. Conditions were: 
8 ,US pulse width (90’ flip angle), 4000 Hz spectral 
width, 16K data points, 3 s recycle time and 256 
scans. Intensity of the water signal was reduced 
when necessary with the help of a 0.5 s presatura- 
tion pulse. Natural abundance proton-decoupled 
13C NMR spectra were obtained from the same 
samples used in the ‘H NMR analysis but ap- 
propriately combined and concentrated after 
lyophilization and resuspension in D20. Condi- 
tions were: 20~s pulse width (90’ flip angle), 
20 kHz spectral width, 16K data points and 2.4 s 
recycle time. ‘H and 13C chemical shifts are 
reported vs internal TSP. 
The two-dimensional homonuclear correlated 
spectrum, 2D COSY [7], was collected using a 
512 x 2048 time domain matrix, averaging the 
signal over a 16 step phase cycle for each tl value. 
As in conventional ‘H NMR spectra, the solvent 
line was suppressed with continuous irradiation 
along the cycle except during the tl and tz periods. 
Sine-bell window functions were used along the tl 
and t2 directions prior to 2D Fourier transforma- 
tion, the final 2D frequency domain spectrum (1K 
x 1K) being further improved by triangular 
symmetrization. 
‘H NMR spectral variations within the pH inter- 
val 1.5-11 .O were analyzed to assist in the 
assignments of resonances and select the most ap- 
propriate conditions for signal quantitation. The 
dissociation equilibrium of the NH; group in 
taurine and glutamate in the extracts happens to be 
a slow process on the NMR time scale and indepen- 
dent signals for the zwitterionic and anionic forms 
are observed [cSGI~~ (Hyy’) 2.350, ~GI~-(&Y') 
2.230; &auf (Haa’) 3.295, Srau-(Haa’) 3.015; 
s ra,,*(H,@‘) 3.440, &a&-I&?) 3.0351. This in- 
convenience, which complicates both spectral 
assignments and resonance quantitation, was 
found to be adequately eliminated by obtaining the 
spectra at pH 8.0. 
Quantitation of the ‘H NMR resonances in 
terms of concentration was achieved through com- 
parison of the intensity per contributing proton of 
the appropriate resonance with that of the alanine 
methyl doublet, after determining enzymatically 
the concentration of this amino acid [8]. To deter- 
mine the intensity, the integral value was used for 
isolated signals. For partially overlapping signals, 
the sum of heights of the multiplet component 
lines measured on an expanded scale was found to 
be more reliable. Optimal proton signals used in 
quantitation (table 1) were selected among those 
arising from the same metabolite on the basis of 
either complete resolution or minimal coalescence 
with neighboring resonances. Correction factors 
were introduced in the calculations to account for 
small differences in signal amplitude due to dif- 
ferent relaxation times or non-resolvable long- 
range couplings. 
2.3. Amino acid analysis 
Amino acid content in the same samples used in 
the ‘H NMR quantitative analysis was also deter- 
mined by quantitative ionic exchange chroma- 
tography on an automatic amino acid analyzer 
(Biotronik Corp., FRG). 
- 
Fig. 1. High-resolution (360 MHz) ‘H NMR spectrum of acid soluble metabolites from adult rat normoxic brain. (A) 
High-field portion; proton signal positions for different metabolites are indicated. (B) Expanded region (6 4.2-3.2 ppm) 
of the spectrum depicted above showing myo-inositol multiplets; assignments, couplings and chemical shifts are also 
presented. NMR conditions were as described in section 2. 
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Creatine phosphokinase, lactate and alanine 
d~hydrogenases were obtained from Boehringer 
Mannheim (FRG). Creatine, creatine phosphate, 
amino acids and nucleotides were purchased from 
Sigma (St. Louis, MO). Deuterated solvents and 
TSP were obtained from Stohler (Waltham, MA). 
The rest of the reagents were of the highest purity 
available commercially. 
3. RESULTS AND DISCUSSION 
Fig.lA depicts the high-meld portion of a 
representative high-resolution ‘H NMR spectrum 
of an extract of acid-soluble metabolites from rat 
brain. Well resolved resonances of various amino 
acids, creatine, creatine phosphate, glycerol 
phosphorylcholine, phosphorylcholine and lactate, 
which have been previously identified [l-3], have 
been pointed out. We have further checked their 
correct assignment on the basis of their pH titra- 
tion behavior, correlations found in the 2D CGSY 
“H NMR spectrum and internal standard addi- 
tions. Expected proton signal connectivities were 
found in the 2D COSY spectrum (not shown) for 
all metabolites detailed in tables 1 and 2. 
The group of signals indicated in fig. IB re- 
mained unassigned. These resonances were also 
correlated in the 2D COSY ‘H spectrum and 
displayed the proton coupling values presented in 
the inset of fig.lB, Couplings, shifts, reIative in- 
tensities and the fact of being non titratable signals 
lead us to identify this relatively major spectral 
component as myo-inositol. This assignment was 
further checked through the addition to the sample 
of a myo-inositol internal standard which co- 
resonated with the formerly unidentified signals. 
Further evidence was obtained from the natural 
abundance 13C NMR spectrum of the original 
samples in which boo-inositol gave rise to 4 promi- 
nent signals in a clean zone of the spectrum at 6 
77.00, 75.06, 74.09 and 73.77 ppm (relative inten- 
sities 1 : 2 : 1: 2) which corresponded to carbons C5, 
Cl-C3, C2 and C4-C6, respectively (not shown). 
It should be noted that no ~yo-inosito1 signals 
have been observed in reported ‘H NMR spectra of 
normal muscle [9], liver (101, serum [tl] or tumor 
cells [ 121. In addition, preliminary experiments in- 
dicated that cerebral free myo-inositol content 
might show important interspecies variations, 
170 
since analysis of the ‘H NMR spectra of acid ex- 
tracts from adult dog brain revealed significantly 
higher concentrations than those found in the rat 
(M. Rico and S. Cerdan, unpublished). 
Some other previously unassigned signals in the 
high-field region of the spectrum corresponding to 
minor components are afso marked in fig.lA: 1y- 
glucose (H 1’ , S 4.672) and ~-hydroxybutyrate 
(methyl, 6 1.210). The low-field zone of the spec- 
trum (not shown) presents resonances assignable to 
AMP (H8, 6 8.596; Hl’, 6 6.155), ADP (H8, d; 
8.514; HI’, 6 6.160), ATP (H8, 6 8.522; Hl’, 6 
6.160), NAD (H2, S 9.330; H6, S 9.130; H4, 6 
8.830; H8, S 8.4321, CTP (H8, 6 8.166), Phe 
(H ortho, S 7.342; I-I,,, and Hpm, S 7.4421, Tyr 
(%a, 6 6.912 and I-&<, 6 7.206) and His (H2, S 
7.740; H5, S 7.050). The relative intensity of this 
portion of the spectrum is considerably smaller 
than that of the high-field zone. 
An important aspect derived from the identifica- 
tion of myo-inositol ‘H NMR signals is the 
possibility of obtaining by NMR quantitative in- 
formation on the myo-inositol content of the brain 
and its eventual changes during physiological or 
pathological situations. Simultaneously, informa- 
tion on the concentration of a fairly large number 
of cerebral metabolites can be obtained quickly 
and reliably. However, before a correct interpreta- 
tion of the quantitative NMR results can be made, 
validation of the NMR data by comparison with 
values obtained by other techniques is needed. 
Table 1 shows an illustrative comparison between 
the cerebral content of a number of metabolites as 
determined by ‘H NMR and values obtained for 
the same samples using more conventional tech- 
niques such as enzymatic analysis or ion-exchange 
chromatography. Specific proton signals used in 
the quantitation along with their chemical shifts, 
multiplicities, assignments and the range of 
previously reported values for the corresponding 
metabolites [13,15,16] are also included. A high 
degree of agreement is found between the values 
determined by ‘H NMR, those obtained by 
chemical analysis and the range of concentrations 
previously reported in the literature, thus support- 
ing the results obtained in our NMR quantitative 
analysis. 
As a first application of this methodology, table 
2 summarizes the variations observed in ‘H NMR 
detectable metabolites during brain maturation. 
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Table 1 
characterization of ‘H NMR signals (360 MHz, 2O”C, pH 8.0) used in the quantitation of rat 
brain metabolites and comparison of metabolite content (ctmol/g dry wt) as determined by ‘H 
NMR with other analytical techniques 
July 1985 
Meta- 
bolite 
Signal identification 
6 (ppm) Muha Assignment 
Content 
(‘H NMR) 
Contentb RangeC of 
(other reported 
techniques) values 
Thr 1.324 
Lac 1.336 
Ala 1.483 
N-Ac-Asp 2.027 
GABA 2.306 
Glu 2.348 
Gln 2.453 
Asp 2.800 
PC 3.234 
GPC 3.244 
Tau 3.420 
GlY 3.562 
myo-in0 3.619 
Cr 3.942 
PCr 3.962 
d 
d 
d 
S 
t 
m 
dmd 
S 
S 
t 
dd 
S 
S 
Me 
Me 
HG%* 
Me 
H&Y, 
%H,, 
H,H,, 
J&? 
N-CH2- 
N-CH2- 
H/3&f* 
%FI,, 
H4,H6 
tIp]EIcy, 
HW%, 
1.6 -+ 0.2 
7.4 I! 1.2 
1.8 t 0.2 
22.9 f 2.4 
5.5 & 0.5 
32.2 + 2.5 
16.3 + 2.4 
8.9 f 0.5 
1.4 * 0.2 
3.0 * 0.2 
11.8 f 2.2 
3.4 f 0.3 
18.8 + 2.5 
20.3 * 0.5 
12.7 -t 1.5 
2.5 + 0.2 
4.7 i- 0.9 
1.9 f 0.2 
31.2 -+ 5.4 
14.1 rfi 2.1 
7.1 ?I 1.4 
10.1 Z!Z 1.9 
3.5 * 0.5 
19.5 III 2.1 
10.8 + 1.6 
0.4- 1.3 
4 -6 
0.6- 4.3 
21.7-44.5 
l.l- 3.8 
36.0-57.6 
9.9-25.8 
7.1-12.5 
1.2 
2.2 
5.8-24.7 
2.5- 6.7 
14.1-28.2 
24.8-35.4 
15.0-22.7 
a Multiplicity: s, singlet; d, doublet; dd, doublet of doublets; t, triplet and m, multiplet 
b All values were determined on the same samples used in the ‘H NMR analysis by quantitaive 
ion-exchange chromatography, except values of lactate, creatine and phosphocreatine, which 
were determined by enzymatic analysis [5] 
’ Values are taken from [13] and quotations therein, except those of creatine, upper limit of 
creatine phosphate, PC, GPC and myo-inositol which were taken from [4], [15] and [16f, 
respectively. A wet wt/dry wt ratio of 4.6 determined experimentally was used to convert 
literature data expressed in wet wt units to dry wt units 
Results are the mean + SE of 6 independent experimental observations on adult rats 
Well defined changes in free amino acid content 
have been described to occur during cerebral 
development. ‘H NMR results obtained in this 
study closely parallel those obtained by ion- 
exchange chromatography [ 141. N-Acetylaspar- 
tate, glutamine, y-aminobutyrate and aspartate 
content increased with age while alanine and 
taurine decreased. Interestingly enough, free myo- 
inositol content increased 2-fold during the first 8 
weeks after birth and continued to rise until the 
sixth month. 
Finally, if our rat brain methanol/HCl/per- 
chloric acid extract is compared to those reported 
in [l] for (a) rat brain acid extract, (b) excised 
brain tissue or (c) in vivo, very similar relative con- 
centrations of the different ‘H NMR observable 
metabolites are found, and most relevant, myo- 
inositol signals (particularly those of protons 
Hl-H3 and H4-H6) can be followed in the spec- 
trum of excised brain tissue or even in vivo. 
Decreased myo-inositol content has been 
associated with the protective action of lithium in 
mania f16J and the development of diabetic 
neuropathy [ 1’71. fn addition, a triphosphorylated 
derivative of myo-inositol, myo-inositol 1,4,5-tri- 
phosphate is thought to act as a second messenger 
of intracellular calcium-mobilizing hormones [ 181. 
This report opens a promising way of studying 
myo-inositol metabolism non-invasively using lH 
NMR. 
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Table 2 
Effect of development on the content @mol/g dry wt) of 
some relevant ‘H NMR (360 MHz) detectable 
metabolites of rat brain 
Metabolite Age (days) 
6 60 180 
Thr 3.5 * 0.3 1.4 * 0.2 1.9 * 0.3 
Lac 5.8 + 0.8 7.5 + 1.2 7.0 + 0.9 
Ala 5.8 + 0.7 1.8 k 0.2 1.8 + 0.3 
N-AC-ASP 3.5 k 0.4 25.0 + 1.8 29.0 k 2.1 
GABA 3.3 + 0.5 5.6 k 0.5 6.9 * 0.5 
Glu 13.0 + 1.1 30.5 + 1.9 33.8 + 2.2 
Gln 11.1 + 1.1 16.7 k 2.4 20.2 & 2.5 
Asp 3.8 + 0.4 9.3 f 0.5 11.3 -e 0.5 
PC 2.8 +- 0.4 1.5 * 0.2 1.4 * 0.2 
GPC 0.9 * 0.3 2.7 + 0.2 3.3 + 0.6 
Tau 26.7 + 2.0 12.9 + 2.2 15.0 + 2.0 
Gly 6.3 k 0.7 3.4 * 0.3 3.6 k 0.2 
myo-In0 9.7 + 1.0 21.5 k 2.5 24.4 k 1.8 
Cr 12.7 + 1.1 20.4 2 0.5 20.0 + 1.0 
PCr 5.8 f 0.9 12.1 + 1.5 14.0 + 0.8 
Results are the mean + SE of not less than 5 independent 
experimental observations 
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